Background: The increase in the number of patients with COVID-19 on a global scale made the early recognition of severe forms of the disease essential. Considering that IL-6 acts as a pro-inflammatory mediator, mediating acute phase responses, the objective of this study was to assess its value in the early severity stratification of SARS-CoV2 infection.
Materials And Methods: It was a prospective study included IL-6 measurement in patients with SARS-CoV2 infection upon admission to the emergency department.